Due to the finely regulated GM-CSF response to sepsis in time and space, intravenous or subcutaneous injections could have reached negative results because of mixed benefic and adverse effects that could be ameliorated by adding GM-CSF in specific tissues or organs and/or timepoints. This evidence concerns the gene CSF2 and Sepsis.